Skip to content
OpenCapital
Get started

New Horizon Aircraft HOVR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price

Other financials

Income statement

See full
Operating income-$7.6M-114%
Net income-$6.9M-39.6%
EPS (diluted)-$0.16+5.9%

Balance sheet

See full
Cash & equivalents$19.7M+114%
Total debt$89.0K+154%
Total equity$14.1M+102%
Total assets$21.9M+112%

Cash flow

See full
Operating cash flow-$6.8M-160%
CapEx$140.0K+53.8%
Free cash flow-$7.0M-156%

Valuation

See full
Market cap$119.82M+153%
Enterprise value$100.24M+151%

Returns & leverage

See full
Return on equity-297.2%—
Debt / equity0×0.0×
Current ratio14.8×+7.7×

Where this comes from

Reported directly by New Horizon Aircraft in its filing.

Tagged under the XBRL concept hovr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice.

The official record: New Horizon Aircraft’s 10-Q, filed April 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about New Horizon Aircraft's share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is New Horizon Aircraft's share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price?
New Horizon Aircraft (HOVR) reported share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price of $11.49 in Q4 2025.
How has New Horizon Aircraft's share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price changed year-over-year?
New Horizon Aircraft's share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price increased by 24.4% year-over-year, from $9.24 to $11.49.